Title of article :
A Case of Aripiprazole-Induced Tardive Dyskinesia withDramatic Evolution
Author/Authors :
Heitzmann, Edwige NorthAlsaceMentalHealthClinic (EtablissementPublicdeSant ́e Alsace Nord (EPSAN) - Brumath, France , Javelot, Hervé NorthAlsaceMentalHealthClinic (EtablissementPublicdeSant ́e Alsace Nord (EPSAN) - Brumath, France , Weiner, Luisa Psychiatry Department - University Hospital of Strasbourg - Strasbourg, France , Michel, Bruno OMEDIT Alsace - Facult ́e de Pharmacie-Laboratoire HuManiS (EA 7308) - Service Pharmacie-CHRU de Strasbourg - Strasbourg, France
Abstract :
Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardivedyskinesia could be higher than initially thought. We report the case of aripiprazole-induced tardive dyskinesia with dramaticevolution in a patient with several risk factors, including older age and exposure to antipsychotic over a period longer than sixmonths. This case and its dramatic evolution, associated with other cases recently published, suggest reconsidering the real risk oftardivedyskinesiaassociatedwitharipiprazole,particularlyintheelderly
Keywords :
Aripiprazole-Induced Tardive Dyskinesia , Dramatic Evolution , Second-generation antipsychotics (SGAs)
Journal title :
Case Reports in Psychiatry
